Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005017232 | SCV005640921 | pathogenic | Polycystic kidney disease, adult type | 2024-03-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004726386 | SCV005335712 | pathogenic | PKD1-related disorder | 2024-08-26 | no assertion criteria provided | clinical testing | The PKD1 c.3420delC variant is predicted to result in a frameshift and premature protein termination (p.Gly1141Alafs*30). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Frameshift variants in PKD1 are expected to be pathogenic. This variant is interpreted as pathogenic. |